AfDB mobilises $2.2bn for Nigeria’s agro-industrial hubs Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

Biztoc.com

Google Flexes Its Tech Muscles With Quantum Computing Chip, Waymo

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

GlobeNewswire

The Kingdom Of Saudi Arabia Artificial Intelligence (Ai) Market Is Expected To Reach Revenue Of USD 61,854.4 Mn By 2033, At 46.6% Cagr: Dimension Market Research.

Biztoc.com

2 Artificial Intelligence (AI) Stocks to Buy Right Now That Could Make You a Millionaire

newsBTC

Bitcoin Nears $100,000: Market Expert Predicts $200K Surge Amid Retail FOMO And Volatility

Forbes

The Push And Pull Of Sino-American Chip Politics

Biztoc.com

Alphabet stock adds $136 billion in market value after it unveils quantum computing breakthrough

Decrypt

Bitcoin Miner MARA Buys Another $1.1 Billion Worth of BTC

Forbes

SpaceX Stock Is Going To The Moon—Are You Joining The Liftoff?

The National Interest

Locked in the Skies: the Chinese and American Air Superiority Contest

GlobeNewswire

Cell and Gene Therapy Market is expected to reach a revenue of USD 111.4 Bn by 2033, at 19.3% CAGR: Dimension Market Research

The Daily Hodl

Treasury Department’s FSOC Says Stablecoins Represent Potential Risk to US Financial Stability

Yahoo Entertainment

黃金不只避險！詹璇依：資產配置新選擇定期定額更適合

Noticiaslatam.lat

¿Cómo la industria automotriz de China podría afectar al mercado mundial del petróleo?

The Times of India

Adani Group vows ₹7.5 lakh crore investment across sectors

The Irish Times

Israel moves tanks into Golan Heights demilitarised zone and strikes ‘strategic targets’ in Syria

Bleeding Cool News

Moana 2 Powers Another Weekend Box Office Of Records

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

GlobeNewswire

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients